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Abstract: This article reviews recent disclosures of bio-inspired, bio-mimicked and bionanotechnologies. Among the 
patents discussed is a nanoscale porous structure for use in nanocomposites and nanoscale processing. Patents disclosing 
methods for printing biological materials using nanolithography techniques such as dip-pen technology are discussed, as 
are patents for optimizing drug design. The relevance of these technologies to disease prevention, disease treatment and 
disease resistance is discussed. The paper closes with a review of cell-based computing and a brief examination of how 
information technology has enabled the development of these technologies. Finally a forecast of the how these 
technologies are likely to accelerate global entropization is discussed as well as a new classification of machine types. 
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INTRODUCTION 
 In the upcoming years we are likely to see nanotech-
nology maintaining the momentum of the recent biology 
revolution and to enable what Freeman Dyson refers to as 
“Our Biotech Future” [1]. Much of what has occurred since 
the discovery of the structure of DNA has been enabled by 
molecular biology, computer technology, computer science, 
and advanced imaging methods. Emerging nanotech-
nological methods that not only image and measure, but that 
also synthesize and manufacture are likely to transform 
medical technologies and to improve human health. 
Preeminent among the fields of health care to be impacted 
will be drug discovery, tissue engineering, and human-
machine interfaces. Automated gene sequencing tech-
nologies and DNA manufacturing technologies, coupled 
with NMR and protein crystallography results are beginning 
to elucidate structure-function relationships between genes 
and proteins, something that was only proposed fifty years 
ago [2], and which came to be known as the “Central 
Dogma” of biology [3]. As correlations and relationships 
between individual genomes and individual health patterns 
are established, the rate of discovery and prevention is likely 
to accelerate, especially through projects such as the Human 
Variome Project [4]. This paper discusses some of the recent 
patents of devices, methods and models that are likely to 
enable the engineering of devices that can interface directly 
with the human nervous system, alter human behavior by 
tailored drug delivery, or even DNA replacement. This will 
be enabled by machines that directly manipulate either single 
cells and molecules either rapidly in small batches or in a 
highly parallel manner, replacing traditional flask and stir-
plate chemistry techniques. Already, novel technologies and 
techniques are enabling the communication and interrogation 
of individual cells and molecules. See for example, advances 
in single DNA manipulation and detection [5-7]. 
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SURFACE PATTERNING PATENTS 
Nanolithography 
 Nanolithography technologies are likely to play a 
prominent role in affecting the rate of drug discovery by 
promoting other technologies such as cell-based sensing e.g. 
[8, 9] or cell-based computing e.g. [10-16]. The ability to 
pattern surfaces, especially electrically active surfaces is 
critical to the success of these technologies, especially as 
cells of various phenotypes are employed. The following is 
an abridgement of several patents that are likely to enable 
such technologies. A recent patent entitled “Method and 
apparatus for mesoscale deposition of biological materials 
and biomaterials,” invented by Gregory Marquez, and 
Michael J. Renn [17], describes a method for deposition of 
an aerosolized biomaterial consisting of an aerosol stream 
using a carrier gas that deposits material onto a target surface 
in a digitized pattern. Aerodynamic focusing of the aerosol 
stream attached to a print head deposits patterns with feature 
sizes ranging from 5 – 200μm, onto flat or featured targets. 
This method has the advantage of avoiding the use of masks, 
but its limited feature size places it in a category of devices 
similar to the Nano eNabler
TM
, available commercially from 
BioForce Nanosciences Inc. Potential deposition materials 
are numerous and are listed in the disclosure to include: 
conductive metal precursors, nanoparticle metal inks, 
dielectric and resistor pastes, biocompatible polymers, and a 
range of biomolecules including peptides, viruses, proteina-
ceous enzymes, extracellular matrix biomolecules, as well as 
whole bacterial, yeast, and mammalian-cell suspensions. 
This type of application is especially valuable for techno-
logies such as biosensor rapid prototyping and microfa-
brication, lab-on-chip manufacturing, biocompatible elec-
troactive polymer development, hybrid BioMEMS, bio-
optics, and microfabrication of biomedical devices. 
 In this technology, fluid viscosity and inclusion size 
dictate the aerosolization mode. For example, biological 
solutions with viscosities of approximately 1-10 cP require 
ultrasonic transducers or pneumatic nebulizers. Ultrasonic 
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aerosolization is also frequently used for cell wall disruption 
and could thus be used for an application where this process 
is required. For solutions with viscosities of approximately 
10-1000 cP, pneumatic aerosolization is used. Above 1000 
cP, aerosolization cannot be performed without dilution with 
an appropriate solvent. Pneumatics and ultrasonic aeroso-
lization allow for the generation of droplets or droplet/ 
particles with sizes typically in the 1-5 μm size range. One 
drawback of this technology is that the pneumatic aeroso-
lization process typically requires a carrier gas flow rate that 
exceeds the maximum allowable gas flow rate through the 
deposition head. To accommodate this need, a “virtual 
impactor” is frequently used such as in the M3D
®
 process to 
reduce the flowrate of the carrier gas after aerosolization. 
 The patent also mentions, but does not claim right to use 
electromagnetic fields such as generated by a laser to heat, 
evaporate, cross link, sinter thermally decompose, melt or 
photochemically decompose features. This has particular 
relevance for biocompatible culturing targets and can be 
used to simultaneously deposit multiple materials through a 
single or multiple deposition heads. The deposition mecha-
nism uses picoliter amounts of biomaterials, depositing them 
via arrays of microneedles tapered from 50 μm at the base to 
5 μm at the tip, with a length of 200 μm. If this technology 
were to be coupled with even smaller microneedles from 
emerging nanofabrication techniques, e.g. [18], and open-
loop or closed-loop 3D nanomanipulation strategies e.g. 
[19], printing resolution would be enhanced. 
 In another nanolithography application, a group of 
inventors from Grand Ledge, Michigan describe an appa-
ratus and process for manufacturing changes of a substrate in 
a work region that is 100100100 μm or smaller [20]. The 
apparatus uses a plasma source adjacent to the work region 
to produce radiation or matter that changes the surface. The 
authors also suggest that an AFM or laser can additionally be 
used. One of the primary uses cited is MEMS production. 
For example, some of the processes claimed are adding and 
removing, dividing and assembling, or manufacturing 
materials and parts to enhance reliability and efficiency in 
manufacturing of micro or nano devices.  
 The authors claim that manual nanomanipulation is 
complex and time-consuming. For a recent example of an 
open-loop nanomanipulation task see [19]. They also cite the 
problems with thermal drift during AFM imaging. This is 
exemplified especially in imaging biological samples e.g. 
[21]. Instead they contend that automatic path planning is 
crucial for nanomanufacturing [22]. The authors intend to 
use microplasma sources with a nanoscale ion beam source 
having beam energies from 50 – 100 eV, a free radical 
capable of operating in several gases, and a UV light. The 
preferred minimum size for the ion, free radical and photon 
beams is 50 nm in diameter using a grid/aperture technology 
in a nanoscale processing system mounted adjacent to 
existing AFM technology allowing the operation of a plasma 
source and subsequent AFM imaging. The source is mounted 
with nanometer-resolution position control. Evaluation of 
both deposition and etching processes is done initially on flat 
surfaces and then the processing is applied to more complex 
three dimensional shapes. 
 For example, a 1-mm diameter discharge operating with 
5% hydrogen in argon at pressures of 10's of Torr has a 
power density of several 100 W/cm
3
 and the electron/ion 
densities are of the order of 10
12
 cm
3
 at the low mTorr 
pressures and are above 10
14
 cm
-3
 in the higher operating 
pressure regime. Because of tip geometry, smaller diameter 
discharges are even more intense having power densities of 
around 1000 W/cm
3
. However, even while discharge power 
densities are high, because of the small volumes involved, 
the total absorbed power is low: typical absorbed power 
levels are a few watts for short discharges, a few tens of 
watts for centimeter-long discharges. These devices thus 
only require a 25-150 watt microwave power supply. 
 The authors also employ and “augmented reality 
system,” the aim of which is to provide the operator with 
real-time visual dynamic AFM image of the operating 
environment. The image is updated locally based on real-
time force information obtained by the AFM tip. Similar 
technologies exist for haptic feedback during AFM 
experiments [23]. In this scheme, the AFM tip acts as a robot 
end effecter for manipulation, and a sensing device to obtain 
the interaction force between the tip and the environment. A 
manipulation of tens of nano particles can take several weeks 
to finish using scan-design-manipulation-scan scheme. But it 
only took about two hours to assemble a complex pattern 
consisting of an “MSU” logo which consists of several 
hundred nanoparticles. 
ARRAYING PATENTS 
Microtissue Arrays 
 Microtissue arrays are likely to become an increasingly 
relevant biotechnology and will be driven by the need for 
high-throughput drug screening. In a recent patent for 
analyzing microtissue arrays, Foran and Chen [24] 
incorporate several established image processing algorithms 
for performing quantitative immunohistochemistry for the 
purpose of identifying the presence and prevalence of a wide 
array of biomarkers relevant to a multitude of diseases and 
conditions. The majority of the patent outlines methods for 
storage, manipulation, retrieval and sharing of microarray 
data via the internet using web-based technologies. The 
inventors describe a process for aligning microarrays of 
tissue that have been stained with either one or two stains 
then for decomposing the color intensities of individual 
regions of the array so that protein expression levels may be 
quantified. The techniques have been applied to tissue 
microarray specimens stained with 3, 3’ diaminobenzidine 
(DAB) chromogen and counter-stained with hematoxylin, 
resulting in various shades and combinations of the two dye 
colors. The patent includes a statement that provides for 
identifying regions of interest and normalization of the data 
to a standard image so that protein expression levels may be 
compared across samples. It covers an algorithm for using 
low magnification to initially align the array under a 
microscope where initial data acquisition is performed, 
followed by a series of high-magnification image captures so 
that a higher quality images can capture multi-resolution 
texture and morphometric measurements. Of major 
significance of the patent is its coverage of a protocol that 
allows clinicians at remote locations to simultaneously view 
and discuss images via web-based technology. The patent 
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does not cover RNA expression levels. The patent also 
covers systems for controlling the system over the internet. 
This technology holds promise to accelerate the rate of 
disease detection and to reduce the risk of false positives by 
allowing multiple clinicians simultaneous access to histology 
samples. However, in order to be effective, it must be 
coupled with other recent processes for initial detection such 
as contrast-enhanced MRI e.g. [25] and targeted delivery 
treatment methods e.g. [26].  
 Nanoscale array sensing combined with patterning is 
perhaps the next step in nanolithography evolution; repre-
senting a hybridization of nanolithography and imaging, or 
in some instances, nanomanipulation and imaging [27]. A 
recent patent, “Biomarker sensors and method for multi-
color imaging and processing of single-molecule life 
signatures” [28], describes another nanoarraying device e.g. 
[29-32] for use in life sciences and diagnostics. This and 
related nanoarraying technologies e.g. [33-35] are likely to 
become increasingly relevant for disease screening, tissue 
engineering, and forensics research. The disclosure describes 
a device consisting of an array of active regions for use in 
reacting one or more chemical or molecular species in at 
least two of the active regions in a sequential process. The 
device has a transparent surface substrate covered by a silane 
material and an active region overlying the silane. Typical 
dimensions of the feature sizes and separations between the 
arrayer are less than 1μm. The device is capable of making 
multiple passes to specific regions of the substrate for the 
purpose of providing a means of performing chemical 
reactions in pulses of approximately 10 μs.  
 The inventors claim that their invention “has a much 
broader range of applicability than typical dip-pen 
technologies since it can be applied to the formation of 
patterns using biological materials, chemical materials, metal 
materials, polymer materials, solid state materials, molecule 
structures of 100 atoms and less, dendrimers, DNA, proteins, 
semiconductors, insulators, organic thin films, inorganic thin 
films, any combination of these, and the like.” Similar to 
existing nanolithography stations, the environment can 
maintain a specified humidity from about 22% to about 92%. 
The system also has a substrate temperature control strategy. 
The probe has a ~5 - 20 nm thick coating that is chemically 
inert, relative to a chemical and/or protein ink, and is a 
hydro-phobic material, such as Teflon™. Optionally, the ink 
solution includes a surfactant such as polysorbate 20. The 
active regions are spatially separated by 30 - 100 nm with 
one active region separated by an arbitrarily small distance 
from another active region using the dip pen process. The 
active regions have dimension of 100 – 300 nm. The system 
has also been designed to perform fluorescence monitoring 
with a two-component fluorophore. The inventors claim to 
use a combination of steps including an undisclosed way of 
forming a micro-array of deposited molecules or with a 
surfactant species to transfer single or multiple molecules 
from an AFM probe tip onto a selected region of the 
substrate. The authors also describe an elaborate plan for 
protein synthesis that combines the advantages of aqueous 
media chemistry with the spatial precision of atomic force 
microscopy. Since synthetic schemes rely on multiple 
sequential steps in aqueous or organic solvents, and 
nanoscopic patterning is usually carried out in air, an 
electrochemical AFM-based nanolithographic technique is 
proposed. In the inventors’ scheme, a conducting AFM 
probe tip serves as an amperometric electrode to generate 
extremely localized amounts of excess acid in buffered 
aqueous solution through the electrolysis of water limiting 
the diffusion field of the free acid to just a few nanometers of 
the probe. Rapid reactions of the electro-generated protons 
with the conjugate base of a weak acid result in a sharp pH 
gradient near the tip. The acid near the probe surface 
selectively removes acid-labile dimethoxytrityl (DMT) 
protecting groups from the 5 ends of oligonucleotides 
immobilized on a substrate and in close proximity to the 
probe. However, since the pH of the bulk solution is much 
higher, the acid-labile protecting groups on the functiona-
lized substrate outside of the tip interaction region remain 
intact. Subsequent steps add a specific monomer to the 
deprotected oligonucleotides only at regions defined by the 
probe tip. This electrochemical synthetic scheme has been 
successfully applied and described in two publications. One 
involves the construction of fluorescent patterns on glass at 
40 μm pitch, using dimethylformamide (DMT) deprotection 
chemistry [36], and in the other demonstrates the production 
of nucleic acid and polypeptide micro-arrays (100 μm 
diameter sites separated by 100 μm) [37].  
BIONANOMATERIALS PATENTS  
 Biological performs may begin to replace some classes 
of light-duty composite materials. Preeminent among all 
biomaterials are the naturally occurring proteins. Nearly 
three billion years of evolution has produced the versatile 
collagen [38, 39], capable of supporting tensile loads in 
tissues such as ligament [40], cornea [41], nerve [42-44] 
(Fig. 1) and skin [45] compressive loads in tissues such as 
cartilage e.g. [46] and bone e.g. [47] and is likely to remain 
critical to tissue engineering applications [48].  
 Biomimicry, the ability to exploit existing biologically 
derived materials with a nanoporous structure is likely to 
obviate the need for artificial nanocomposites in some 
applications. A patent by Darby and Darby [51], “Process for 
making biopreform from monocotyl caudex plant, 
biopreform” describes a method of making biopreform from 
the stems of monocotyledonous plant suitable for liquid 
infiltration and gaseous transportation of materials. The trees 
used include coconut, Cocos nucifera, palmyra palm, 
Borassus flabellifer, and date palm, Phoenics dactylifera. 
The plants are dried under pyrolytic conditions to create a 
material with microstructural features consistent with those 
of the parent plants. Similar processes for making silicon – 
silicon carbide ceramics using the same biopreform, but at 
temperatures of 1450° to 1600° C could potentially create 
materials with similar properties, but with higher humidity 
tolerance. Compared with zeolites, the process is performed 
at lower temperatures, has porosities of similar size and 
distribution, and may prove to have better mechanical 
properties than other emerging nanocomposite materials. 
Briefly, the process involves slowly heating a stem in the 
range of 350° to 1000° C, maintaining the stem piece at the 
peak temperature under self-generated ambient atmosphere, 
then cooling it to obtain the biopreform. The microstructure 
of the resulting material is nearly identical to the precursor 
plants. The inventors claim their biopreform to be useful in 
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preparation of numerous composite materials: ceramics, 
carbon-epoxy, carbon-metal, carbon-silicon carbide, carbon-
metal oxide, silicon-silicon carbide, metal-silicon carbide, 
transitional metal silicide-silicon carbide, aluminum oxide-
aluminum nitride, and silica silicon nitride. The structures 
may also be used for gaseous transportation or liquid 
infiltration, reaction and substitution or suitable combination 
of such processes. These materials have particular 
application for industries such as aerospace, automotives, 
sports equipment and even replacement-limb prosthetics.  
 The temperatures used indicate that pyrolytic weight loss 
is practically completed by 600° C and that heating at a rate 
up to 5° C per minute up to 750 to 800° C indicates complete 
pyrolysis and typically no collapse, distortion, or graphiti-
zation of cellular structure, and that mineral residues are not 
converted into stable compounds, ensuring that the 
biological structural features of the parent plant are 
preserved. What remains to be determined is the material’s 
susceptibility to water damage. As this bio-derived matrix 
has a structure that evolved to imbibe and transport water, it 
may be susceptible to soaking in water, leading to 
degradation. Other similar structures include naturally grown 
porous structures such as those found in ocean sponges e.g. 
[13]. Presumably if the material were to be used as an 
impregnated composite, or if it were to be treated with a 
shell of impenetrable material, this would be less likely. The 
materials used were grown in tropical climates such as those 
found in India, the southeastern United States and other 
countries where palm trees are prevalent. The biopreform 
characteristics vary depending in the specific species used 
and preparation protocol, but they have been observed to 
contain pore sizes of a bimodal or trimodal distribution: 70 
to 120 m, 6 to 20 m and 1 to 5 m. The biopreforms have 
been characterized by X-ray diffraction and found to contain 
non-graphitic carbon. What the authors do not discuss, but 
something that future investigators might benefit from, 
would be the intentional formation of a graphitic phase such 
as that recently developed [52]. If successful, and if used in 
combination with a diffusion of atomic carbon gas, the 
technology of this patent could have the potential to make 
continuous carbon nanotubes with larger diameters than 
those currently achievable using conventional catalytic 
processes.  
MOLECULAR DESIGN PATENTS 
 The ultimate nanotechnology is one in which an object is 
manufactured one atom or molecule at a time. This mode of 
assembly has been postulated for years by innovators such as 
Robert Freitas [53] and Eric Drexler [54]. However, other 
more practical methods for building materials from so-called 
self-assembly methods, especially in monolayer formations, 
have proved to be more efficacious, at least in the short-term 
e.g. [55-57]. Arguably, the most advanced molecular syn-
thesis system is the pentad of protein synthesis molecules: 
ribosomes, tRNA, aminoacyl-tRNA syntetases, mRNA, and 
protein factors [58]. However, there have also been recent 
attempts to mimic the molecular manufacturing machinery 
developed by nature. For example, in “Algorithmic design of 
peptides for binding and/or modulation of the functions of 
receptors and/or other proteins,” Mandell, Selz, and Shlesin-
ger [59] cover with a comprehensive abstract, “Methods of 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). At the nanoscale, a single collagen fibril looks much like a helical rope. The image on the left is an atomic force microscopy image 
of an individual collagen fibril with two neighboring fibrils [49]. The figure on the right is a 40 nm  40 nm portion of the fibril 
superimposed with a backbone model of the collagen triple helix, the full length of which is approximately 300 nm. The two arrows 
represent the fibril axis (left) and the molecular axis (right) [50]. As nanotechnology and advanced microscopy techniques advance, greater 
resolution images of individual molecules are expected. However, the level of resolution seen in this image, taken in 2001 of a single fibril 
with minimal sample preparation, remains unsurpassed. 
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synthesizing a peptide or peptide-like molecule to a 
polypeptide or protein target based on mode-matching each 
member of a set of peptide constituents of the peptide or 
peptide-like molecule to peptide constituents of the target 
polypeptide or protein target.” The primary purpose of the 
broadly defined invention is to enable greater specificity and 
targeted labeling of proteins either in vivo or in vitro. The 
authors state that “the ability to accurately identify and track 
protein expression is fundamental to the study of all diseases 
and to the study of all of bioscience.” The method disclosed 
uses three interrelated techniques to statistically characterize 
a polypeptide's physicochemical properties for constructing 
peptides with a high probability of binding to a target pro-
tein, polypeptide or peptide. The first method is eigenvector-
based. An eigenvector is determined from the autocovariance 
matrices of a sequentially tagged physicochemical property 
data series of the peptides, polypeptides and proteins for both 
the original data series and the target series. An eigen-
function is then constructed from the convolution of these 
two eigenvectors. The second technique uses a maximum 
entropy power spectral transformation to categorize, classify 
or otherwise describe a protein based on its entropy or 
information content. The third uses discrete and continuous 
wavelet transformations, one-dimensional wavelet packets 
and multiple convolved wavelets to confirm the dominant 
statistical wavelengths of the eigenfunctions and locate them 
as phase amplitudes or absolute valued moduli in the 
constituent sequences. The target sequence list is exhaustive, 
covering “any protein involved in protein-protein interac-
tion” but explicitly names cell membrane receptors, nuclear 
membrane receptors, circulating receptors, enzymes, 
membrane and circulating transporters, membrane proteins 
involved in the translocation of viral and other infective 
agents into the cell, chaperonins and chaperonin-like 
proteins, monoclonal antibodies and antibody derivatives. 
The method is based on creating graphs of the leading 
eigenfunctions of the target protein's smoothed hydropathy 
sequence, to form an ordered set of hydrophobic free energy 
(Ghp) eigenfunctions.  
 The primary impact of this invention will be in the fields 
of laboratory medicine as well as enabling new discoveries 
in molecular biology. For example, a sequence of a particular 
polypeptide that is associated with a disease condition is 
known, then peptides that will bind, modulate the function 
of, activate, or inhibit those polypeptides may be synthesized 
using the methods of this invention. When used to treat a 
tumor, the peptide could be conjugated to or incorporated 
with a cytotoxic agent, such as a radioisotope or a toxin, or 
could be attached to a nanoparticle sensitive to ultrasonic 
heating as recently demonstrated by [60]. When used for 
detection, the peptides could be conjugated to a molecule 
that can be visualized or otherwise detected, such as a 
radioisotope, a chromophore or a fluorophores such as a 
quantum dot. The peptides developed using the invention 
could be used to screen tissue or blood samples for the 
presence or absence of a particular polypeptide. Sample 
types listed by the authors include blood, plasma, blood 
products, urine samples, fecal samples, tissue biopsy 
samples, skin samples, semen samples, and epithelial cell 
samples. When used to screen for tumors or disease 
conditions, or when used as a therapeutic, the developed 
peptides could be included as a component in a diagnostic or 
therapeutic kit, respectively. While the use of peptides for 
screening in such applications is well known, the primary 
utility of the invention is to reduce the need for undue 
experimentation. 
 Molecular design for drug delivery has seen an 
explosion of forms in recent years. In a patent entitled 
“Polymeric micelles for drug delivery” [61] the inventors 
describe a method for designing a drug-loaded micelle 
comprised of a multiblock copolymer consisting of several 
poly amino acid blocks. One intended purpose for the 
invention is the treatment of cancer. The primary intellectual 
property of this invention is that it employs three main 
components: a polymeric hydrophilic block, a crosslinked 
poly amino acid block, and a third poly-amino acid block. At 
the tertiary scale, the micelle has three main characteristics: 
an inner core, a crosslinked outer core, and a hydrophilic 
shell. The inventors cite doxorubicin and camptothecin as 
two examples of drugs that may be delivered through their 
invention, but the patent states that the general method may 
be used to deliver a multitude of nanovectors such as 
siRNAs or MRI contrast agents. The patent also covers 
micelles with reactive surface functionality for attachment of 
drugs, permeation enhancers, and targeting groups. The 
patent describes a method of sequential polymerization, 
wherein a first monomer such as N-carboxy anhydride 
(NCA), lactam, or imide is incorporated into the polymer, 
followed by a second monomer to form a second amino acid 
block. The multiblock copolymers covered consist of one 
synthetic polymer portion and two or more poly amino acid 
portions (W—X—X), where W is a synthetic polymer 
portion and X and X are poly amino acid chains or “amino 
acid blocks”. For example, the multiblock copolymers could 
consist of triblock copolymers if three polymer portions are 
employed or tetrablock copolymers if four regions are 
present. The hydrophilic polymers used for this particular 
application are the well-known polyethylene oxide (also 
referred to as polyethylene glycol or PEG), poly(N-vinyl-2-
pyrolidone), poly(N-isopropylacrylamide), poly (hydroxy-
ethyl acrylate), poly(hydroxylethyl methacrylate), and 
polymers of N-(2-hydroxypropoyl)methacrylamide (HMPA). 
The patent claims to cover the use of covalently linked 
natural or synthetic poly amino acid or amino acid blocks of 
the L-configuration and include those with “protected” 
functional groups such as amino acid monomers with 
hydroxyl or amino moieties. 
 The inventors denote that a “living polymer chain-end” is 
the terminus resulting from a polymerization reaction that 
maintains the ability to react further with additional 
monomer or with a polymerization terminator. This “living 
end” is analogous to the end of the C-terminus of a protein 
where polymerization takes place on a ribosomal complex. 
The inventors also define “detectable moiety” or “label” as 
any moiety such as primary or secondary labels capable of 
being detected. For example, a primary label might be a 
radioisotope-containing moiety such as 32P, 33P, 35S, or 
14C. Primary moieties could also be mass-tags such as gold 
nanospheres. They could also take the form of fluorescent 
labels, which generate a light signal when excited. 
Secondary labels as defined by the inventors include 
“moieties such as biotin, or protein antigens that require the 
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presence of a second compound to produce a detectable 
signal.” For example, for biotin labels, the second compound 
might be a streptavidin-enzyme conjugate. In the case of an 
antigen label, the second compound could be an antibody-
enzyme conjugate. Fluorescent groups are also frequently 
used as secondary labels and are possible candidates for 
secondary labels in this application as well. A popular 
emerging technology for protein detection is a process 
known by the acronym, FRET (fluorescent resonance energy 
transfer) whereby energy is transferred to another compound 
or group in a non-radiative manner, causing the second 
compound or group to generate a detectable radiative signal. 
 The key to the technology is the use of amphiphilic 
multiblock copolymers. An amphiphilic molecule is one that 
has a hydrophobic and a hydrophilic end. Perhaps the most 
common example of an amphiphilic (or amphipathic) 
molecule is a phospholipid such as is found in nearly every 
living cell. It consists of one end that is typically comprised 
of a carbon atom bound with three hydrogen atoms. Its 
fourth bond holds it to the molecular backbone. The 
hydrophilic end of the molecule can vary in its chemical 
characteristics, but is likely to be charged, thus attracting 
polarized water molecules. The most common amphiphilic 
artificial substance is soap: polarized water sticks to one side 
of the water molecule and unpolarized skin oils bind the 
other. If these molecules form a monolayer that becomes 
spherical, a micelle forms. By contrast, a liposome is a bi-
layered sphere of amphiphilic molecules. In the present 
invention, the inventors have developed a method for self-
assembling nano- and micron-sized structures in water. 
When present in solution above the critical micelle 
concentration (CMC), their amphiphilic multiblock 
copolymers assemble by “multi-molecular micellization.” 
There are various theories as to how this occurs, but the 
inventors favor the mechanism whereby the hydrophobic 
poly(amino acid) portion or “block” of the copolymer 
collapses to form the micellar core, while the hydrophilic 
PEG block forms a peripheral corona and imparts water 
solubility.  
 The inventors also cite their work as falling under a 
larger realm of chemistry, known as “click chemistry,” a 
term accredited to 2001 chemistry Nobel laureate, K. Barry 
Sharpless. Click chemistry is commonly defined as “selec-
tive, exothermic reactions which occur under mild conditions 
in water.” The inventors state that certain R3 moieties, or 
molecules with three functional groups, of the present 
invention are suitable for click chemistry. The R3 moiety is 
useful for conjugating their micellar compounds to 
biological macromolecules such as proteins, viruses, and 
cells. Because most proteins contain a multitude of lysines 
and arginines, with their long, charged sidechains, micelle 
conjugation occurs uncontrollably at multiple sites on the 
protein. The authors contend that this is problematic when 
lysines or arginines are located around the active site of an 
enzyme or other biomolecule. They thus present another 
method for conjugating the R1 groups of a compound to a 
macromolecule via click chemistry.  
 They state that since click reactions tend to involve high-
energy, “spring-loaded” reagents with well-defined reaction 
coordinates, they give rise to a wide scope of selective bond-
forming events. Examples include the nucleophilic-trapping 
or strained-ring electrophiles (epoxide, aziridines, aziridi-
nium ions, episulfonium ions), certain forms of carbonyl 
reactivity (aldehydes and hydrazines or hydroxylamines, for 
example), and several types of cycloaddition reactions. The 
azide-alkyne 1,3-dipolar cycloaddition is named as one such 
reaction. In discussing the release mechanism, the authors 
contend that although the design of materials that respond to 
small pH variations is challenging, this mechanism, coupled 
with the enhanced permeability and retention (EPR) effect 
that their micelles may represent an effective method for 
limiting drug release to solid tumors. The EPR effect [62] 
has been observed in tumor treatment whereby the increased 
micro-vasculature at a tumor site makes it selective for small 
liposomes or macromolecular drugs. The advantage the 
authors state to their invention is that their amphiphilic block 
copolymers and cell-responsive polymer micelles are 
designed to combine the concepts of crosslinked polymer 
micelles and pH-sensitive drug targeting to construct “smart” 
nanovectors that are infinitely stable to dilution in the 
bloodstream but are “chemically programmed” to release 
their therapeutic payload in response to pH changes 
commonly found in solid tumors and cancer cells. They 
conclude their discussion on delivery by contending that by 
utilizing cancer-responsive nanovectors in conjunction with 
chemotherapeutic agents, clinical problems such as post-
injection micelle stability and the targeted delivery of 
encapsulated therapeutics to cancer cells are mitigated. 
Unlike previous examples of micelle crosslinking strategies 
such as core and shell crosslinking, the multi-block approach 
of this group allows for the effective crosslinking of polymer 
segments located at the interface of the hydrophobic and 
hydrophilic polymer blocks as shown in Fig. 2. This 
approach is advantageous because stable micelles are 
prepared without sacrificing loading efficiency or altering 
the drug molecule during core crosslinking. The remainder 
of the patent lists several hundred drugs, either synthetic or 
biologically derived, that may be used in their targeting 
strategy. 
BIOLOGICAL-BASED COMPUTING 
 The now well-known heuristic theory of computer 
technologist, Gordon Moore proposed in 1965 and now 
commonly referred to as Moore’s Law has been applied to 
everything from the number of transistors on a chip [63, 64], 
to the number of cell phones in use [65], to the general rate 
of biological and technological development from the Big 
Bang to the present [66, 67]. In fact, Ray Kurzweil has used 
Moore’s Law to predict that technological computation will 
surpass individual “human computation” within this century 
and indeed all of humanity’s computational power shortly 
thereafter [65]. But what is biological computation? DNA 
has been used to solve the traveling salesman problem [68], 
but arguably, computation also occurs in the brain at a rate of 
approximately 10
18
 – 10
18 
computations per second, (10
12
 – 
10
13
 neurons with 10
3
 connections each operating at 1 kHz). 
What computation occurs within a single cell? 
 In “Knowledge-Based Methods for Genetic Networks 
and Systems Based Thereon,” Edwin Addison of 
Wilmington, NC, describes “A new computing architecture 
that mimics the behavior of biological cells, called a “Whole 
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Cell Computer” (WCC) [69]. The WCC computational 
architecture is based on the biochemical processing of cells. 
It represents both a specialization and an extension of 
“membrane computing.” The computing strategy is derived 
from the properties of biological cells and has extensive 
statistical redundancy built in. Presumably, cells can also be 
“programmed” using genetic programming techniques. The 
inventor describes the WCC as “a computing node that 
operates in a network of many other WCCs of similar or 
different types, wherein: 
 a) the WCC operates by the principles of stochastic 
dataflow computing; 
 b) the WCC is classified as a membrane computer; 
 c) the WCC substantially obeys one or more basic 
principles selected from the group of: 
i. the WCC has at least one membrane bound instruction 
within it; 
ii. the WCC instructions convert one or more operands into 
one or more operand products and may optionally require the 
presence of additional operands that do not undergo change, 
and instructions execute upon the arrival of all necessary 
operands within a proximal distance to the instruction, which 
distance is determined by rule or instruction; 
iii. a state vector of the WCC provides information about 
results or status of which are determined by the statistical 
aggregate expression level and state vector as a result of the 
random motion and aggregate execution of instructions; 
iv. programs are stored as one or more strings of embedded 
operands in a latent state, and programs execute by arrival of 
activating or regulating operands; 
v. the WCC contains a “cache” memory, which maintains a 
single copy of each individual instruction that is active in a 
given WCC; 
vi. the WCC contains at least one of the following types of 
inputoutput instruction: 1) instructions that cause operands to 
cross membrane boundaries, and/or 2) instructions that 
respond to ligands; 
vii. the WCC contains an operating system that provides the 
mechanism for copying instructions and operands from 
programs, delivering them to the proper location, and 
providing the power for their execution upon the arrival of 
their operands; 
viii. WCC program execution is massively parallel, 
distributed, multithreaded and otherwise contains no central 
processing unit; 
ix. memory and computing results are stored via the state of 
WCC in a distributed manner, with short term memory of the 
WCC being the current state vector, and the the long term 
memory of the WCC being the active pathways;  
x. when there are differing types of WCCs in a network, 
there must be more then ten copies of each type;  
xi. a WCC is robust to computing errors because there are 
many copies of any given instruction, operand or WCC in a 
network; 
xii. a WCC may cease to function by its own decision if it 
becomes defective; and 
 d) the WCC may be programmed by manually fixing the 
instruction set and operands or through genetic program-
ming.” 
 As described by the inventor, and as outlined in a 2000 
NSF report, biological computing is a research area wherein 
the goal is to determine how biology performs information 
technology from the subcellular level to the systems and 
population level, and determines computing architectures to 
mimic these processing techniques [70]. Although contro-
versial [71], the cell itself may be considered to be a 
computing machine. Observations supporting the notion that 
a cell is a computer are that a cell contains many enclosed 
organelles, each of which perform specific simultaneous 
operations. The operations likely have varying degrees of 
interrelatedness. For example, the cell nucleus, typically 
located near the geometric center of the cell, contains and 
protects its code in the form of DNA. The DNA is read by a 
complex of enzymes, is transcribed into RNA, and ultimately 
produces operands in the form of proteins, which then either 
diffuse, or are chemically directed spatiotemporally through-
out the cell or indeed throughout the organism to perform 
signaling operations. This cluster of processes provides the 
computational kernel. Cellular computations are also 
mediated by external stimuli such as protein hormones, 
metabolism of food (proteins, fatty acids or sugars) or 
 
 
 
 
 
 
 
Fig. (2). Schematic comparing the triblock co-polymer method Breitenkamp et al. (2006) [61] to existing micelle drug-release methods. 
Image adapted from [61]. 
 
H+
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metabolites such as electrolytes or oxygen. The primary 
operations of the cellular computer are constitutive; 
maintaining basal the power supply of the cell, while other 
processes conduct duties that may promote the importance of 
an individual cell such as exocytosis regulation and signal 
transduction. The substrates upon which most of these 
processes take place may be considered to occur in one of 
two places: the cytosol or the cell membrane. The cytosol, 
primarily consists of water and a multitude of proteins in 
various phases of construction and editing and the cyto-
skeleton. The cell membrane, nuclear membrane and mem-
branes of the various organelles consist of a lipid bilayer and 
its associated integral proteins such as ion channels (Fig. 3), 
which may be considered as the I/O interface of the cellular 
computer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Atomic force microscopy image of a nuclear membrane 
imaged on a gluteraldehyde-fixed intact nucleus extracted from an 
embryonic rat liver cell. Clearly visible are individual ion channels, 
which appear as small volcano-like structures. Image taken during a 
mitochondria isolation and imaging protocol [21]. Larger structures 
seen as large white clusters may be individual nuclear membrane 
pore complexes. Image size = 2μm  2μm. 
 
 Since the cellular computing platform is highly parallel, 
highly redundant, and highly distributed, no single operation 
is ultimately critical to producing a final result. The results 
of computation are based on the concentration of operands, 
which are based on thousands or millions of chemical 
reactions. The inventors saliently state that  
 “Unlike traditional computing where every line of code 
could potentially crash a program, cells “compute” with the 
second law of thermodynamics.” 
 The uncertainties and inefficiencies often attributed to the 
second law also govern silicon-based digital computers, 
where voltages must “threshold” when changing states. The 
second law also dictates that purely reverersible computing 
[72] is not possible, but approachable, just as perpetual 
motion is an idealization of a machine that is frictionless. 
Another intriguing property that the inventors ascribe to 
whole cell computing is “evolvability,” where programm-
ability is based on genetic recombination. The notion that 
entropy production, life and indeed information theory [73] 
are deeply intertwined has been explored in detail by others 
[74-77].  
 What remains to be determined, and something that is 
likely to become of deep importance to science, the 
environment, and indeed global technology policies is the 
rate of entropy production of a given technology or entity. 
For example, the well-known second law of thermodynamics 
states that when energy is transformed from one form to 
another, for example from thermal to mechanical, the 
entropy of the system increases. The same is true if the same 
system exchanges some of its mechanical energy for thermal 
energy. Thus, as repeated exchanges are made, entropy 
continues to rise until sufficient disorder exists such that 
further exchange becomes either impractical, uneconomical, 
or impossible.  
 With regard to biological computing, the inventor cites a 
lineage of leaders in neural networks [78], genetic 
programming [79, 80], artificial intelligence e.g. [81], DNA 
computing [68], molecular computing e.g. [82], and bacterial 
computing [83]. Returning to the Hickman NSF report [70], 
there is a “huge untapped potential” in cellular computing 
and currently research in the area is “scattered, not well 
focused, and often very application-oriented.” One cause 
perhaps is that computer scientists have thought biology to 
be uninteresting because of their slow metabolic speed. The 
realization that biological systems may be exploited for their 
parallelization is changing this notion. While this may be 
true for a single cell, when a cell is seen as a computing 
element and the focus is on what is inside of a cell as in the 
invention of Addison, computational steps can be very fast at 
the molecular level. Addison goes on to state that one goal of 
the research within the patent is to simulate a portion of a 
human immune system. He cites this as an example of using 
a network of WCCs cooperatively to do intelligent pattern 
recognition. He states that:  
 “The immune system is a highly distributed, complex and 
asynchronously parallel system of cells, antibodies, antigens 
and signaling molecules. To simulate lymphocyte response 
requires differently defined WCCs for each element of the 
system. For example, a different WCC architecture 
(instructions, compartments, concentrations) is needed for a 
B-lymphocyte, an antigen and an antibody, among others. 
Specific actions are simulated by defined instructions in each 
WCC type. For example, a common action in the immune 
system is when an antigen is presented to a lymphocyte 
causing the release of cytokines [84]. This leads to the 
specification of instructions and “cell organization” by 
modeling the specific action. The biochemical pathway 
causing the release of cytokines may be identified by 
referencing the KEGG database[85]. This pathway then 
represents the model of a WCC instruction. In the overall 
simulation, when an antigen comes in contact with the 
lymphocyte, that instruction sequence will be activated, 
causing an increase in the concentration of “cytokines”, an 
object which can trigger other WCC instructions. Then, the 
overall dynamics of a “system” or network of WCCs 
determines the overall outcome. In this case, the overall 
outcome may be a mapping of the number of active 
lymphocytes as a function of time, where an “active” 
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lymphocyte is one whose concentration level of a specific 
operand is above a certain level, the choice of which may be 
determined by genetic programming.” 
 Some further limitations of the current state of WCC 
listed by the inventor are that the proposed WCC architec-
tures do not yet fully take advantage of high volume of 
cellular transactions and the second law of thermodynamics. 
He views a cell as a computing element or processor as an 
interrupt-driven dataflow machine that processes many 
instructions in parallel and uses may subordinated proces-
sors, and states that ultimately, the cell’s role is to send and 
receive various communications (electrical, chemical) with 
other cells at various points in time. He states that a cell is a 
dataflow machine: instructions in the form of chemical 
reactions execute when their operands (i.e. reactants and 
enzymes) arrive. He then states that there is no sequential 
program of instructions as in the von Neumann machine. 
While this may be true for a single cell or a group of cells, 
there are a multitude of homeostasis enzymes that work 
serially checking for errors in DNA, maintaining ion 
gradients, and maintaining cell temperature. Thus while a 
whole cell certainly is not a von Neumann-type serial 
processor, it does contain several processes that are indeed 
serial. 
 A deeper question that lies at the heart of cellular 
computing is whether the human operator (scientist) can 
understand the processes of whole cells or groups of cells to 
a degree sufficient to compete with silicon transistor-based 
computers. For example, if we are to view machines as 
evolving through a process known as “mechanoevolution,” 
[86] then machines are selected for based on a fitness 
criteria. In the case of computation, the fitness criteria is 
based upon two metrics: the ability to perform calculations 
quickly and the ability of a significant number of human 
operators to program a given computational device to render 
it effective. For example, to be selected for, whole cell 
computing must either provide enough advantage to a 
limited few who are capable of conducting cell based 
computing, or it must be simple enough to allow a larger 
number of people to use it such that it becomes ubiquitous. 
 Addison states in his patent the often quoted adage that 
“it is easier to learn to fly by building airplanes than by 
dissecting birds”. Aircraft efficiency and bird efficiency may 
both be defined as the amount of energy used to overcome 
drag divided by the amount of chemical energy stored in the 
fuel. Computational efficiency must be defined in a different 
way. Since the purpose of the computer is not to move 
quickly and efficiently, but rather to organize data or 
information, its efficiency must be defined by the number of 
computations per second divided by the power used or 
computations per joule. A typical desktop computer 
performs a few hundred million computations per second, 
consuming approximately 100 joules per second. By 
comparison, the 10 to 100 trillion cells in the human body 
share approximately 5000 Calories (20 megajoules) of 
energy daily, thus each cell consumes on average, energy at 
a rate of 1 to 10 picowatts. Using the figures above, the 
desktop computer executes approximately one million 
computations per joule. A cellular computer with a mass of 
10 kg consisting of one trillion cells would need to have each 
of its cells performing 1,000,000 to 10,000,000 computations 
per second to compete with silicon-based computers. 
 An ideal Turing machine is zero-dimensional, or at most 
one dimensional. The computational framework of the 
present patent is perhaps two dimensional (if a membrane is 
being used as the input/output) or three dimensional if the 
whole cell is considered. The one-, two-, or three-dimen-
sional state space of a computer may be defined, however by 
a single zero +1 space where all of the information contained 
in the one binary square of the Turing machine is given 
sufficient time to pass through it. 
CURRENT & FUTURE DEVELOPMENTS  
 One underappreciated attribute of biologically manufac-
tured materials is that they are all constructed molecule-by-
molecule under enzymatic control and are always 
manufactured at ambient temperatures, whereas nearly all 
industrial processes involve heating either a pure material or 
a solution or combination of compounds to produce a desired 
shape. In the author’s opinion, a true challenge for nano-
technology is to harness the “information” contained by the 
enzymatic processes of nature. Herein lies the secret to 
bottom-up manufacturing.  
 To the author’s knowledge, no formal global efficiency 
analysis has been performed for manufacturing technologies. 
Typically, manufacturers try to keep their costs low by using 
a minimum amount of energy to make a part. In general, 
anything that is manufactured spends a period of time at an 
elevated temperature as it is being formed. It then cools and 
takes its final shape or configuration. This is true for 
manufacturing processes ranging from glass blowing to 
magnetic disk drive fabrication. Arguably, once a part has 
been manufactured, it has greater information content than 
the material had prior to the manufacturing and it is this 
information content that makes the manufactured item more 
valuable. This is true for anything from Michelangelo’s 
David, which has a greater value than the stone from which 
it was carved to the kitchen stove, which has greater value 
than the sheet metal from which it was made. The specific 
spatial orientation of the atoms in these artifacts determine 
their value. What is frequently ignored however, is the rate 
of entropy production during the manufacturing process and 
the relative rate of entropy production among manufacturing 
processes. Since at the macroscale, no process is truly 
irreversible, when energy is exchanged from one form to 
another (i.e. thermal to mechanical), entropy is produced. An 
intriguing study would be to quantify the entropy production 
rate of a given nanofabrication technique and to compare it 
to a traditional fabrication technique. For example in a 
carbon vapor deposition process, a catalytic process is used 
and temperatures of 600°, up to 2000° C are reached at 
various stages in the process, to produce typically a few 
micrograms of material. By contrast, all of the bone, dentin 
and collagenous tissue in all organisms are produced at less 
than 40° C. Likewise, a nanomanipulation or microfabri-
cation process typically involves movement of a robotic arm 
many million times as massive as the device being 
assembled, whereas enzymes such as DNA polymerase, 
which are true nanoassemblers, have masses equal to or less 
than the molecules they produce. Thus if a low-temperature 
enzymatic molecule were to be invented that “spun” carbon 
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nanotubes or other nanofibers, this would be a true step 
forward for making nanotechnology smarter, more efficient, 
and environmentally friendlier since less combustion 
products would be emitted during their manufacture.  
 As a closing remark, I would like to introduce a classifi-
cation of machines. These may be generally defined as Type 
I, Type II, Type III, or Type IV machines. A Type I machine 
is one that requires no power input and which is not itself 
responsible for entropy generation without human input. An 
example of a Type I machine is a hammer. A Type II 
machine is one that requires a non-human power source and 
thus performs energy conversion such as from electrical to 
mechanical, and is thus capable of entropy generation both 
during operation as well as maintenance. An example is an 
automobile, which converts chemical energy into thermal 
and mechanical energy during operation, but which also 
requires the use of several other Type I machines such as 
wrenches, pliers, etc., for its maintenance. A Type III 
machine on the other hand, is nearly capable or fully capable 
of self-maintenance and thus generates entropy whether or 
not a human is immediately present to operate it. Examples 
include advanced robots or some advanced assembly plants. 
Societies that are able to develop, maintain and utilize 
machines of increasing levels of complexity i.e. Type III 
versus Type I typically enjoy a greater standard of living. 
However, what has not been fully analyzed is the effect of 
the accelerating of “entropization,” that humans have on the 
environment. We know that the second law states that dS > 
dE/T, where S is entropy, E is energy, and T is temperature. 
Since we assume that energy is always exchanging states and 
that an increasing amount of this state change is driven by 
human innovation, the second law is sometimes stated as 
dS/dt > 0, where t is time. However, what has not been 
considered, is whether this rate of entropy is accelerating, 
i.e., d
2
S/dt
2
 > 0, is constant, d
2
S/dt
2
 = 0, or is diminishing, 
d
2
S/dt
2
 < 0. It is my contention that since living systems are 
always working towards deceleration of their own entropy 
production rates and that of their technologies, that the net 
result is an acceleration in the global entropy level (Fig. 4). 
A definition of Type IV machine, is perhaps less clear, but 
may be generally defined as one that only serves a purpose 
when fully integrated with human anatomy. A common 
example is a pacemaker or insulin pump. Ultimately these 
machines will diminish further in size, perhaps reaching the 
dimensions outlined in the inaugural issue of this journal 
[87]. Once this scale has been reached, and indeed once 
nanorobots have become integral portions of our own germ 
cells, we will evolve into Type IV machines as predicted by 
Kurzweil [88]. 
 For example, the majority of the technologies reviewed 
in this article operate on vanishingly small volumes of 
material. In some cases the volume is as small as a few 
picoliters (10
-15
 m
3
, or 10  10  10 μm) or femtoliters (10-18 
m
3
, or 1  1  1 μm) of space. However, the equipment that 
must be maintained to perform these manipulations still 
requires up to a kilowatt of power. For example, to manually 
assemble a nanopippette, using a nanomanipulator requires 
that two or three computers be running as well as a high-
voltage electron beam, not to mention one or two microscope 
operators [19]. By contrast, at the macroscale, to build a 
stone wall or to frame a house, considerably more mass is 
being moved per unit time, with only two hundred watts 
from a human. Perhaps the most extreme example of this 
inverse relationship between the amount of energy required 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Quantitative model of entropy production in a universe with and without life, which strives to reduce entropy locally. For example, 
it is well known from the second law that dS/dt is positive, but as advanced technologies are developed to reduce entropy within individual 
human organisms, will global entropy production accelerate? 
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to manipulate matter and the length scale upon which it is 
being manipulated is manifested in particle accelerators 
which are now reaching dimensions of several tens of 
kilometers in circumference, and where the critical operating 
volume is that of a single atomic nucleus 10
-30
 to 10
-45
 m
3
. 
The energy required to operate such as system can approach 
that of an average sized city. In other words, the devices used 
to probe matter at the subatomic scale must be tens of 
kilometers miles in diameter and consume tremendous 
energy to monitor events taking place in nanoseconds. Once 
true “picotechnology” comes on line, its cost per unit volume 
is likely to somewhere between the extreme seen in particle 
accelerators and that of current nanotechnology. The true 
question, however, is what the payoff will be for science and 
technology investors.  
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